$Cassava Sciences (SAVA.US)$ Spoke with a Lawyer/ former executive yesterday who has brought many drugs to market specifically with brain functions. He stated that the number one thing that FDA and regulators look for in any drug is safety, does it cause any adverse effect when the patient started taking the drug and made things worse. As We have seen with all the other current drugs for Alzheimer's, they all cause brain bleeding, swelling and death , hence scrutinized and not recommended. SAVA h...

$Cassava Sciences (SAVA.US)$ Here is the Breakdown: SAVA settled with SEC because they know that 40M is nothing compared to what they are going to make when Simufilam becomes Available. FDA still granted them 2 SPA's , agreed for them to continue with OLE Extension as many trial sites and patients requested it and has been deemed safe with several reviews. Did everyone forget about Biogen 2 years ago  that Paid $900M to settle false claims but Biogen is still thriving as a company even though the...

$Cassava Sciences (SAVA.US)$ We need to Question The SEC and DOJ and make sure they file the same charges to Eli Lilly's Donanemab. Why are they not investigated by SEC & DOJ ? Since they charged SAVA 40Million, they need hold accountable all the other ones that actually kill patients, exaggerated their data and paid 8 FDA reviewers to approve their drug that no doctor would recommend. Look at this New Article : "Investigation Discloses Safety, Efficacy Concerns About Eli Lilly's Donanemab"

$Cassava Sciences (SAVA.US)$ NEW SAVA BULLISH PRESS RELEASE “Cassava is pleased to put this matter behind us,” Mr. Barry said. “We can now focus all of our attention on completion of the ongoing Phase 3 trials of simufilam. While no one can accurately predict the future, we remain hopeful that the trials will be successful and that, after a rigorous FDA review, simufilam could become available to help those suffering from Alzheimer’s disease.”

$Cassava Sciences (SAVA.US)$ SEC & DOJ, did you charge Lilly's Donemab that killed patients, payed 8 FDA reviewers to approve it and exaggerated their data , got rejected by doctors and not recommended by anyone. For those reading , The SEC & DOJ are like the Mafia here. They wanted $40 M as their cut now before SAVA takes off and treat Alzheimer's patients, disrupts the old bad ways that all the other companies failed and will make a lot of money when it is approved. Shorts, this is your very la...

$Cassava Sciences (SAVA.US)$ Yes. Bullish. Third New Review of SAVA's Safety . New Article."Simufilam found safe in review of ongoing Alzheimer’s clinical trials
Safety monitory board recommends 2 Phase 3 trials of oral therapy continue. After completing a third review of interim safety data, an independent safety monitoring board has recommended the continuation — without modifications — of two ongoing Phase 3 clinical trials testing the oral therapy simufilam in people with Alzheimer’s disease....

$Cassava Sciences (SAVA.US)$ The Facts are that SAVA has always been deemed safe, requested by patients and trials sites for OLE extension, patient testimonies and will prove again on a larger scale that it is effective. Look at This New Article that is investigating Lilly's Donanemab. Shorts, SEC, DOJ, Seeking Alpha , Adrian H, Jesse B, Bik , Jordan Thomas, if you are truly about ethics than you should have made accusations/investigations about Donanemab. The evidence is clear of SAVA really wor...

$Kintara Therapeutics (KTRA.US)$ What is this SEC? You let this Shorting go on like this for how long? it’s blatant shorts  manipulation .

$Cassava Sciences (SAVA.US)$ These shorts are trying to cheat with printed shares to keep stock price down to $28 for options this Friday. Look at how they are keeping it under $29 then the rest of the week they will try to keep it close to $28. THIS CHEATING | MANIPULATION OF STOCK PRICE HAS TO STOP. Shorts & market manipulators should not control the stock price every day, every week, every Friday for options. This needs to be reported to News Outlets, Investigators & whoever is above SEC and D...

$Kintara Therapeutics (KTRA.US)$ Someone is accumulating big time shares while the market manipulation of stock price. We will see this true stock value fly soon